Sonnet BioTherapeutics, Inc. (NASDAQ:SONN) | WebDisclosure

Basculer en Français

8606	Companies
141263	Keywords
77174	Articles
75484	Press releases

Headlines Articles Press releases Sonnet BioTherapeutics, Inc.

Home
Companies
Sonnet BioTherapeutics, Inc.

PRESS RELEASE

published on 02/29/2024 at 22:05, 1 year 1 month ago

Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability

Clinical Data Sonnet BioTherapeutics SON-1010 Immunotherapeutic Drug FHAB Technology
PRESS RELEASE

published on 02/14/2024 at 13:30, 1 year 1 month ago

Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
Sonnet BioTherapeutics Holdings, Inc. successfully raised $4.55 million, published preclinical data on SON-1210, executed NJ NOLs agreement, Phase 1b SON-080 trial enrollment completed, financial results announced for quarter ended Dec 31, 2023

Financial Results Preclinical Data Public Offering Sonnet BioTherapeutics Holdings NJ NOLs
PRESS RELEASE

published on 12/21/2023 at 14:00, 1 year 3 months ago

Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
PRESS RELEASE

published on 12/14/2023 at 22:15, 1 year 3 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
PRESS RELEASE

published on 10/31/2023 at 12:30, 1 year 5 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
PRESS RELEASE

published on 10/25/2023 at 13:30, 1 year 5 months ago

Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
PRESS RELEASE

published on 10/17/2023 at 14:00, 1 year 5 months ago

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
PRESS RELEASE

published on 09/20/2023 at 13:30, 1 year 6 months ago

Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology

Accesswire

Published on 04/10/2025 at 02:30, 39 minutes ago

Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/10/2025 at 01:40, 1 hour 29 minutes ago

RRS Gather Round Conference Presentation
Published on 04/09/2025 at 23:30, 3 hours 39 minutes ago

AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/09/2025 at 22:17, 4 hours 52 minutes ago

Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Published on 04/09/2025 at 22:05, 5 hours 4 minutes ago

Amdocs Announces Q3F25 Investor Conference Schedule

View all ACCESSWIRE

EQS Group

Published on 04/09/2025 at 20:20, 6 hours 49 minutes ago

Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 6 hours 51 minutes ago

EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 8 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:45, 8 hours 24 minutes ago

EUROPLASMA: Précisions dans le cadre du projet de reprise de la Fonderie de Bretagne
Published on 04/09/2025 at 18:34, 8 hours 35 minutes ago

PolyPeptide announces results of the annual General Meeting 2025

Les Echos

Published on 04/09/2025 at 18:59, 8 hours 9 minutes ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:59, 8 hours 9 minutes ago

Descriptif du programme de rachat d'actions 2025-2026
Published on 04/09/2025 at 18:57, 8 hours 11 minutes ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 18:57, 8 hours 11 minutes ago

Compte-rendu de l'Assemblée Générale Mixte du 9 avril 2025
Published on 04/09/2025 at 17:45, 9 hours 24 minutes ago

COGELEC : Résultats annuels 2024 et Chiffre d’affaires du 1 er trimestre 2025.

View all LES ECHOS COMFI WIRE